NCT04949230

Brief Summary

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

3 years

First QC Date

June 29, 2021

Last Update Submit

February 27, 2024

Conditions

Covid19COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute BronchitisCOVID-19 Acute Respiratory Distress SyndromeCOVID-19 Lower Respiratory InfectionSARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory Disease

Outcome Measures

Primary Outcomes (1)

  • Survey Response

    Answers given by subjects on their recovery from COVID-19

    One hour

Study Arms (1)

COVID-19 Patients

Subjects who have recovered from COVID-19

Other: No Intervention Used

Interventions

No Intervention UsedOTHER

There is no intervention in this study

COVID-19 Patients

Eligibility Criteria

Age18 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1\. Refusal to sign informed consent form

You may qualify if:

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female of 18 years of age or older
  • Diagnosis of COVID-19 infection by RT- PCR
  • Recovery from COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ginger Aurella

Ventura, California, 93003, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Sabine Hazan, MD

    ProgenaBiome

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 2, 2021

Study Start

February 19, 2021

Primary Completion

February 15, 2024

Study Completion

February 15, 2024

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations

US(1)